At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the ...

Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx Constellation outperformed orthogonal methods in identifying select difficult-to-map ...

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

Illumina (($ILMN)) has held its Q3 earnings call. Read on for the main highlights of the call. Illumina’s recent earnings call painted a picture ...

Not satisfied with simply bankrolling Democratic candidates, the National Education Association now offers a compendium of teacher prep materials for educators. The catch? It’s a functional ...

Ultima Genomics has transformed highly efficient, production-scale sequencing while reducing the sequencing cost per genome ...

Using the iconPCR system, n6 presents enhancements in low-pass whole genome sequencing. This approach enables balanced, ...

In today’s rapidly evolving landscape of next-generation sequencing (NGS), researchers face mounting pressure to deliver high-quality data from increasingly diverse and challenging sample types. From ...

Quantum-Si's fundamentals are weak at the moment, and this likely extends beyond market conditions. Click here to find out ...

This study presents valuable findings on the role of KLF6 in in vitro endothelial cells exposed to altered (high or low) shear stress with a customized microfluidic device to investigate mechanisms of ...